How TNF inhibitors have revolutionised pregnancy in RA
A comparison with outcomes in the early 2000s shows remission rates have doubled
Many pregnant women with rheumatoid arthritis (RA) can achieve low disease activity in the third trimester with a modern treatment regimen that includes anti-TNF medications, a study suggests.
Researchers examined data on 309 patients with RA who were pregnant or trying to conceive and undergoing a treat-to-target medication regimen that included anti-TNF medications as well as low-dose prednisone and disease-modifying antirheumatic agents.
